Insulin Pump Recall: Insulet Removes Certain Omnipod 5 Pods
Insulet is removing specific Omnipod 5 Pods due to a risk that a tear in the internal tubing may prevent the device from delivering insulin as intended.
This recall affects Insulet, users of the Omnipod 5 system, and healthcare professionals managing patients who utilize these insulin pump pods.
A failure in insulin delivery constitutes a significant safety risk for patients with insulin-dependent diabetes. From a regulatory perspective, this suggests a localized manufacturing or component quality issue that requires immediate mitigation to prevent potential hyperglycemia or ketoacidosis. Quality teams may need to investigate the root cause of the tubing tears within the assembly or supply chain process.
Regulatory and QA teams should prioritize the identification and quarantine of affected lots. Manufacturing teams should evaluate assembly line integrity to prevent mechanical tubing damage, while Post-Market Surveillance should monitor for similar failure modes in related product lines.
Omnipod Pods may not deliver insulin as intended due to a tear in the internal tubing.
Open in openFDA / FDA.gov